USPTO serial 90976382
CLINITEST
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 12, 2022
- Examiner
- SHEN, ELIZABETH S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CLINITEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Siemens Healthcare Diagnostics Inc.
Tarrytown, NY
Other trademarks owned by Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Tarrytown, NY
Other trademarks owned by Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.
Tarrytown, NY
Other trademarks owned by Siemens Healthcare Diagnostics Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew Chien
Andrew Chien SIEMENS HEALTHCARE DIAGNOSTICS INC.511 BENEDICT AVE.TARRYTOWN, NY 10591UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | diagnostic reagents and chemicals for clinical and medical use, namely, medical diagnostic reagents and assays for testing of body fluids | ACTIVE | Jan 27, 1941 |
| 010 | medical diagnostic test kit comprising of pipettes and test cassettes for identification of the SARS-CoV-2 virus in humans; medical diagnostic instruments, namely, medical diagnostic instruments for the analysis of body fluids | ACTIVE | Oct 1, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Siemens Healthcare Diagnostics Inc.
- Other trademarks owned by Siemens Healthcare Diagnostics Inc.
- Other trademarks owned by Siemens Healthcare Diagnostics Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named CLINITEST
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 10, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 9, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 26, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 26, 2022 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 21, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 7, 2022 | IUAF | USE AMENDMENT FILED | — |
| Jan 7, 2022 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 7, 2022 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 7, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 9, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 7, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 7, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 7, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 4, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 17, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 17, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 17, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 17, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2020 | NWAP | NEW APPLICATION ENTERED | — |